Home page Home page
AstraZeneca

Esbriet
pirfenidone

Package leaflet: Information for the user Esbriet 267 mg hard capsules pirfenidone


Read all of this leaflet carefully before you start taking this medicine because it contains important information for you.

Keep this leaflet. You may need to read it again.


What Esbriet looks like and contents of the pack

Esbriet hard capsules (capsules) have a white to off-white opaque body and a white to off-white opaque cap with ‘PFD 267 mg’ printed in brown ink. The capsules contain a white to pale yellow powder.


Your medicine is provided in either a 2-week treatment initiation pack, a 4-week treatment pack or in a bottle.


The 2-week treatment initiation pack contains a total of 63 capsules. There are 7 blister strips with 3 capsules per strip (1 capsule per pocket for Week 1) and 7 blister strips with 6 capsules per strip (2 capsules per pocket for Week 2).


The 4-week treatment pack contains a total of 252 capsules. There are 14 x 2-day blister strips each containing 18 capsules (3 capsules per pocket).


The blisters strips in the 2-week treatment initiation pack and 4-week treatment maintenance pack are each marked with the following symbols as a reminder to take a dose three times a day:


image (sunrise; morning dose) image (sun; daytime dose) and image(moon; evening dose). The bottle pack contains 270 capsules.

Not all pack sizes may be marketed.


Marketing Authorisation Holder


Roche Registration GmbH Emil-Barell-Strasse 1

79639 Grenzach-Wyhlen Germany


Manufacturer


Roche Pharma AG Emil-Barell-Str. 1

D-79639 Grenzach-Wyhlen

Germany

For any information about this medicine, please contact the local representative of the Marketing Authorisation Holder:


België/Belgique/Belgien

N.V. Roche S.A.

Tél/Tel: +32 (0) 2 525 82 11

Lietuva

UAB “Roche Lietuva” Tel: +370 5 2546799


България

Рош България ЕООД

Тел: +359 2 818 44 44

Luxembourg/Luxemburg

(Voir/siehe Belgique/Belgien)


Česká republika

Roche s. r. o.

Tel: +420 - 2 20382111

Magyarország

Roche (Magyarország) Kft.

Tel: +36 1 279 4500


Danmark

Roche a/s

Tlf: +45 - 36 39 99 99

Malta

(See Ireland)


Deutschland

Roche Pharma AG

Tel: +49 (0) 7624 140

Nederland

Roche Nederland B.V.

Tel: +31 (0) 348 438050


Eesti

Roche Eesti OÜ

Tel: + 372 - 6 177 380

Norge

Roche Norge AS

Tlf: +47 - 22 78 90 00


Ελλάδα

Roche (Hellas) A.E.

Τηλ: +30 210 61 66 100

Österreich

Roche Austria GmbH Tel: +43 (0) 1 27739


España

Roche Farma S.A.

Tel: +34 - 91 324 81 00

Polska

Roche Polska Sp.z o.o.

Tel: +48 - 22 345 18 88


France

Roche

Tél: +33 (0) 1 47 61 40 00

Portugal

Roche Farmacêutica Química, Lda Tel: +351 - 21 425 70 00


Hrvatska

Roche d.o.o.

Tel: +385 1 4722 333

România

Roche România S.R.L.

Tel: +40 21 206 47 01


Ireland

Roche Products (Ireland) Ltd.

Tel: +353 (0) 1 469 0700

Slovenija

Roche farmacevtska družba d.o.o.

Tel: +386 - 1 360 26 00


Ísland

Roche a/s

c/o Icepharma hf Sími: +354 540 8000

Slovenská republika Roche Slovensko, s.r.o. Tel: +421 - 2 52638201


Italia

Roche S.p.A.

Tel: +39 - 039 2471

Suomi/Finland

Roche Oy

Puh/Tel: +358 (0) 10 554 500

Κύπρος

Γ.Α.Σταμάτης & Σια Λτδ. Τηλ: +357 - 22 76 62 76

Sverige

Roche AB

Tel: +46 (0) 8 726 1200


Latvija

Roche Latvija SIA Tel: +371 - 6 7039831

United Kingdom (Northern Ireland)

Roche Products (Ireland) Ltd. Tel: +44 (0) 1707 366000


This leaflet was last revised in


.


There are also links to other websites about rare diseases and treatments.